Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 14656948)

Published in Carcinogenesis on December 04, 2003

Authors

Shugo Suzuki1, Makoto Asamoto, Kazunari Tsujimura, Tomoyuki Shirai

Author Affiliations

1: Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. shugo@med.nagoya-cu.ac.jp

Articles by these authors

MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell (2005) 2.65

Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.23

Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology (2003) 1.19

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate (2009) 1.08

Diet and prostate cancer. Toxicology (2002) 1.07

Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett (2003) 1.07

Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol (2010) 1.03

Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev (2008) 1.03

Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations. Toxicol Appl Pharmacol (2009) 1.03

Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology (2008) 1.02

Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Prostate (2009) 1.02

Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J Toxicol Sci (2002) 1.01

Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. EMBO J (2010) 1.00

Malignant solitary fibrous tumor of the meninges. Virchows Arch (2004) 1.00

Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells. Cancer Lett (2005) 1.00

Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate (2008) 1.00

Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study. Toxicol Appl Pharmacol (2006) 0.99

Expression of prothymosin alpha is correlated with development and progression in human prostate cancers. Prostate (2006) 0.98

TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A (2011) 0.98

Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers. Prostate (2003) 0.97

Silencing of connexin 43 suppresses invasion, migration and lung metastasis of rat hepatocellular carcinoma cells. Cancer Sci (2012) 0.96

Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate (2005) 0.96

A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci (2003) 0.95

Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation. Cancer Sci (2008) 0.95

Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system. Cancer Sci (2004) 0.94

Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core. Prostate (2006) 0.93

Transforming growth factor beta derived from bone matrix promotes cell proliferation of prostate cancer and osteoclast activation-associated osteolysis in the bone microenvironment. Cancer Sci (2008) 0.92

Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci (2010) 0.91

High susceptibility of the ACI and spontaneously hypertensive rat (SHR) strains to 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) prostate carcinogenesis. Cancer Sci (2003) 0.91

Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G. Hepatology (2007) 0.91

Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: a model for prostate cancers in the aged. Cancer Res (2005) 0.91

Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci (2007) 0.90

Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens. Cancer Res (2007) 0.90

Suppression of metastasis by nuclear factor kappaB inhibitors in an in vivo lung metastasis model of chemically induced hepatocellular carcinoma. Cancer Sci (2004) 0.90

Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis. Cancer Sci (2013) 0.89

Lack of mutation induction with exposure to 1.5 GHz electromagnetic near fields used for cellular phones in brains of Big Blue mice. Cancer Res (2002) 0.88

Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology (2004) 0.88

Low-fat milk promotes the development of 7,12-dimethylbenz(A)anthracene (DMBA)-induced mammary tumors in rats. Int J Cancer (2004) 0.88

Lack of adverse effects of whole-body exposure to a mobile telecommunication electromagnetic field on the rat fetus. Radiat Res (2010) 0.87

Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment. Cancer Sci (2003) 0.87

Differences between latent and clinical prostate carcinomas: lower cell proliferation activity in latent cases. Prostate (2006) 0.87

Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine. Jpn J Cancer Res (2002) 0.87

A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicol Pathol (2010) 0.86

DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. Prostate (2002) 0.86

Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. Virology (2008) 0.86

Effects of genetic background on prostate and taste bud carcinogenesis due to SV40 T antigen expression under probasin gene promoter control. Carcinogenesis (2002) 0.86

Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis (2003) 0.85

Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions. Med Mol Morphol (2005) 0.85

Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat. Endocrinology (2007) 0.84

Effects on rat testis of 1.95-GHz W-CDMA for IMT-2000 cellular phones. Syst Biol Reprod Med (2011) 0.84

Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3. Food Chem Toxicol (2012) 0.84

Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer. Prostate (2012) 0.84

Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett (2011) 0.84

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer Res (2008) 0.84

Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci (2003) 0.84

Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation. Exp Toxicol Pathol (2013) 0.84

Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ Mol Mutagen (2002) 0.83

Chronic exposure to a 1.439 GHz electromagnetic field used for cellular phones does not promote N-ethylnitrosourea induced central nervous system tumors in F344 rats. Bioelectromagnetics (2005) 0.83

Pitfalls with MRI evaluation of prostate cancer detection: comparison of findings with histopathological assessment of retropubic radical prostatectomy specimens. Urol Int (2006) 0.83

Effects of gestational exposure to 1.95-GHz W-CDMA signals for IMT-2000 cellular phones: Lack of embryotoxicity and teratogenicity in rats. Bioelectromagnetics (2009) 0.83

Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis. Oncol Rep (2013) 0.83

Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther (2004) 0.83

Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate. Carcinogenesis (2003) 0.82

Optimization of an animal test protocol for toxicogenomics studies (I); requirement study of a protocol. J Toxicol Sci (2007) 0.82

Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Sci (2013) 0.82

Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication. J Membr Biol (2007) 0.82

Influence of atrazine administration and reduction of calorie intake on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats. Cancer Sci (2005) 0.82

Characterization and application of polyclonal antibodies that specifically recognize JC virus large T antigen. Acta Neuropathol (2006) 0.82

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma. Jpn J Cancer Res (2002) 0.82

Optimization of an animal test protocol for toxicogenomics studies (ii); a cross-laboratory gene expression analysis. J Toxicol Sci (2007) 0.82

Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats. Toxicol Pathol (2003) 0.82

Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. J Med Virol (2004) 0.82

Dose response study of conjugated fatty acid derived from safflower oil on mammary and colon carcinogenesis pretreated with 7,12-dimethylbenz[a]anthracene (DMBA) and 1,2-dimethylhydrazine (DMH) in female Sprague-Dawley rats. Cancer Lett (2003) 0.82

Reactive angioendotheliomatosis of the intestine. Am J Surg Pathol (2004) 0.81

Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation. Int J Cancer (2008) 0.81

Ellagic acid inhibits migration and invasion by prostate cancer cell lines. Asian Pac J Cancer Prev (2013) 0.81